Home
Home  >>  Archives  >>  Volume 14 Number 2  >>  st0344

The Stata Journal
Volume 14 Number 2: pp. 407-417



Subscribe to the Stata Journal
cover

Stata command for calculating adverse event and efficacy stopping boundaries for phase II single-arm trials

Bryan M. Fellman
MD Anderson Cancer Center
Houston, TX
bmfellman@mdanderson.org
Abstract.  Many programs and functions in statistical packages focus on the final stage of clinical trials, that is, the data analysis. In this article, I aim to assist in the early stages of clinical trials, specifically, the design of phase II single-arm trials. I present the new command stopbound, which calculates stopping boundaries and operating characteristics based on monitoring an adverse event, efficacy, or an adverse event and efficacy.

View all articles by this author: Bryan M. Fellman

View all articles with these keywords: stopbound, Bayesian clinical trial design, adverse event, efficacy rate, futility, simulation, operating characteristic

Download citation: BibTeX  RIS

Download citation and abstract: BibTeX  RIS

Contact StataCorp

Contact service@stata-journal.com if you have questions about the Stata Journal.

© Copyright 2001–2014 StataCorp LP.   Terms of use.   Privacy policy.